72 related articles for article (PubMed ID: 28544525)
1. A meta-analysis of the association between the ATIC 347 C/G polymorphism and methotrexate responsiveness and toxicity in rheumatoid arthritis.
Lee YH; Song GG
Semin Arthritis Rheum; 2024 Feb; 64():152337. PubMed ID: 38071832
[TBL] [Abstract][Full Text] [Related]
2. Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis.
Liu B; Liu G; Liu B; Guo Y; Peng N; Li T
World J Surg Oncol; 2024 Jan; 22(1):19. PubMed ID: 38212758
[TBL] [Abstract][Full Text] [Related]
3. Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis.
Davis LA; Polk B; Mann A; Wolff RK; Kerr GS; Reimold AM; Cannon GW; Mikuls TR; Caplan L
Clin Exp Rheumatol; 2014; 32(3):324-32. PubMed ID: 24447348
[TBL] [Abstract][Full Text] [Related]
4. ASSOCIATION OF MTHFR A1298C POLYMORPHISM WITH BREAST CANCER AND/OR OVARIAN CANCER RISK: AN UPDATED META-ANALYSIS.
Liu W; Li Y; Li R; Han X; Ma Y; Liu B; Kong X
Afr J Tradit Complement Altern Med; 2016; 13(5):72-86. PubMed ID: 28487897
[TBL] [Abstract][Full Text] [Related]
5. Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry.
Salazar J; Garcia-Planella E; Fernández-Clotet A; Esteve M; Gisbert JP; Busquets D; Lucendo A; Márquez L; Guardiola J; Martín-Arranz MD; Iglesias E; Monfort D; Villoria A; Cañete F; Bell O; Ricart E; Zabana Y; Chaparro M; Domènech E; Gordillo J;
Br J Clin Pharmacol; 2024 May; 90(5):1301-1311. PubMed ID: 38369687
[TBL] [Abstract][Full Text] [Related]
6. Association between MTHFR A1298C polymorphism and hepatocellular carcinoma risk.
Zhang H; Li G; Zhang Z
Int J Clin Exp Med; 2015; 8(6):9135-41. PubMed ID: 26309569
[TBL] [Abstract][Full Text] [Related]
7. The effect of smoking on response to methotrexate in rheumatoid arthritis patients: A systematic review and meta-analysis.
Nayebirad S; Javinani A; Javadi M; Yousefi-Koma H; Farahmand K; Atef Yekta R; Tamartash Z; Mohammadzadegan AM; Salehi S; Kavosi H
Mod Rheumatol; 2023 Dec; 34(1):68-78. PubMed ID: 36688574
[TBL] [Abstract][Full Text] [Related]
8. Barriers and Enablers in the Use of Parenteral Methotrexate in Rheumatoid Arthritis Patients: A Scoping Review.
Tan JM; Reeve E; Fraser L; Proudman SM; Wiese MD
Arthritis Care Res (Hoboken); 2023 Nov; 75(11):2306-2315. PubMed ID: 37128818
[TBL] [Abstract][Full Text] [Related]
9. Effect of methotrexate use on the development of type 2 diabetes in rheumatoid arthritis patients: A systematic review and meta-analysis.
Baghdadi LR
PLoS One; 2020; 15(7):e0235637. PubMed ID: 32628710
[TBL] [Abstract][Full Text] [Related]
10. Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate.
van der Pol KH; Nijenhuis M; Soree B; de Boer-Veger NJ; Buunk AM; Guchelaar HJ; Risselada A; van Schaik RHN; Swen JJ; Touw D; van der Weide J; van Westrhenen R; Deneer VHM; Houwink EJF; Rongen GA
Eur J Hum Genet; 2024 Feb; 32(2):155-162. PubMed ID: 36056234
[TBL] [Abstract][Full Text] [Related]
11. GENETIC PREDICTORS OF TOXIC EFFECTS OF METHOTREXATE IN CANCER PATIENTS.
Fishchuk L; Skavinska O; Ievseienkova O; Rossokha Z; Sheiko L
Exp Oncol; 2024 Feb; 45(4):399-408. PubMed ID: 38328850
[TBL] [Abstract][Full Text] [Related]
12. Association between COVID-19 Infection or Vaccination Outcomes and Methylenetetrahydrofolate Reductase Gene Polymorphism: A Systematic Review of the Literature.
Jukic I; Heffernan A; Schelling AF; Kokic Males V; Savicevic NJ; Kovacic V
J Pers Med; 2023 Dec; 13(12):. PubMed ID: 38138914
[TBL] [Abstract][Full Text] [Related]
13. Severe Adverse Toxic Effects of Low-Dose Methotrexate Treatment on an Ectopic Pregnancy Patient With Methylenetetrahydrofolate Reductase Mutations: A Case Report.
Yu H; Wang W; Liang H; Wang K; Ling B
Front Med (Lausanne); 2021; 8():738315. PubMed ID: 34869432
[No Abstract] [Full Text] [Related]
14. Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence.
Dorado P; M Peñas-Lledó E
Pharmacogenomics; 2024 Jan; 25(2):55-58. PubMed ID: 38230665
[TBL] [Abstract][Full Text] [Related]
15. Are gene polymorphisms related to adverse events of methotrexate in patients with rheumatoid arthritis? A retrospective cohort study based on an updated meta-analysis.
Huang J; Fan H; Qiu Q; Liu K; Lv S; Li J; Yang H; Shu X; Xu Y; Lu X; Lu C; Zhang Y; Xiao C
Ther Adv Chronic Dis; 2020; 11():2040622320916026. PubMed ID: 32426102
[TBL] [Abstract][Full Text] [Related]
16. Association of
Wang S; Zuo S; Liu Z; Ji X; Yao Z; Wang X
J Int Med Res; 2020 Feb; 48(2):300060519879588. PubMed ID: 31617429
[TBL] [Abstract][Full Text] [Related]
17. Genetic Polymorphisms of TYMS, MTHFR, ATIC, MTR, and MTRR Are Related to the Outcome of Methotrexate Therapy for Rheumatoid Arthritis in a Chinese Population.
Lv S; Fan H; Li J; Yang H; Huang J; Shu X; Zhang L; Xu Y; Li X; Zuo J; Xiao C
Front Pharmacol; 2018; 9():1390. PubMed ID: 30546311
[No Abstract] [Full Text] [Related]
18. Lack of association between MTHFR A1298C polymorphism and outcome of methotrexate treatment in rheumatoid arthritis patients: evidence from a systematic review and meta-analysis.
Fan H; Li Y; Zhang L; Li Y; Li W
Int J Rheum Dis; 2017 May; 20(5):526-540. PubMed ID: 28544525
[TBL] [Abstract][Full Text] [Related]
19. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients.
Soukup T; Dosedel M; Pavek P; Nekvindova J; Barvik I; Bubancova I; Bradna P; Kubena AA; Carazo AF; Veleta T; Vlcek J
Rheumatol Int; 2015 Jul; 35(7):1149-61. PubMed ID: 25618758
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
